HerMD
8350 East Kemper Road, Suite A, Cincinnati, OH, 45249, United States
Overview
HerMD offers comprehensive women's healthcare both in-person and virtually, with medical services billed through insurance and Medicare. Appointments average 20–60 minutes, and the company also provides aesthetic services such as facial injectables and body treatments. To address provider training gaps, HerMD created HerMD University, which uses proprietary algorithms of care plus conferences and monthly meetings to train clinicians. The company operates clinics in Cincinnati, Franklin, Tennessee and Carmel, Indiana and has around 20 providers; it consistently sees a waitlist of approximately 500 patients leading up to clinic openings. Founder and chief medical officer Dr. Somi Javaid opened the first location in 2015; Kathy McAleer became CEO in 2022. With the new funding, HerMD plans to expand brick-and-mortar locations (including its first New York City-area site and a second Nashville-area clinic), grow its team, develop virtual services and HerMD University, launch mental-health services, introduce e-commerce and physician-curated products, and invest in sexual-health and menopause technologies. HerMD is a minority, female-founded women’s health startup led by founder and chief medical officer Dr. Somi Javaid, an OBGYN. The company operates two centers in Cincinnati and Crescent Springs, Kentucky, and has attracted patients from 30 states and Canada. HerMD provides specialized sexual health and menopause services, with providers who have specialty training and offerings that include procedures such as Botox for vaginismus. The company accepts insurance for gynecologic procedures and offers discounted self-pay options. HerMD plans to expand with new physical centers and to roll out telehealth to increase access to sexual health and menopause care.
- Total raised
- $28M
- Funding rounds
- 2
- Latest round
- Series A
- Latest activity
- Jul 2023
Industries
- Health Care
- Lifestyle
- Wellness
- Women's
Recent funding
Series A
Jul 2023
$18M
Series A
Feb 2022
$10M